SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms Inc. is experiencing a sharp sell-off as investors react to unfavorable court rulings regarding addictive content and rising concerns over heavy AI capital expenditure. The community is actively debating whether this decline represents a major buying opportunity due to strong fundamentals or a deeper structural shift in social media regulation.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors react to volatility driven by reports of Google's new memory compression technology, which some fear could reduce future demand for traditional memory chips. The community remains deeply divided, with many bulls highlighting the company's strong fundamentals and critical role in the AI supply chain, while others are caught in a broader market sell-off triggered by geopolitical tensions and concerns over cyclicality.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing renewed positive momentum driven by a strategic ad partnership with Pacvue that expands its enterprise-scale advertising capabilities. Investors are closely watching ongoing insider buying, which appears to be tempering concerns surrounding previous executive stock sales.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is experiencing extreme volatility as traders grapple with escalating geopolitical tensions and erratic energy markets, fueling intense community debate over whether to buy the dip or prepare for further downside. Investors are closely monitoring potential diplomatic developments regarding the Strait of Hormuz, with the discourse split between those aggressively scalping the swings and others cautioning that leveraged semi-conductor exposure remains a risky play amidst broader economic uncertainty.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining momentum as investors eye its dual GLP-1/GIP agonist, VK2735, as a high-potential challenger in the multibillion-dollar obesity market. The community remains focused on upcoming trial milestones, viewing the stock as a prime acquisition target due to its clinical progress and clean profile relative to competitors.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is surging after the GLOW2 Phase 3 study for its eye drug, Zenkuda, met primary endpoints with superior results compared to sham treatment. The community is actively discussing a potential short squeeze due to high short interest, while debating whether the current move marks a long-term rerating of the company's platform or a temporary spike prone to profit-taking.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is seeing heightened investor attention and a strong upward trend, driven by robust commercial execution of its lead therapy, Rezdiffra, and speculation regarding potential long-term acquisition interest from major biopharma players. While the community is actively debating the company's high operating expenses versus its market leadership in the MASH space, technical momentum and positive analyst coverage continue to fuel significant bullish sentiment.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is experiencing heightened market attention following a volatile reaction to interim clinical data for its obesity candidate, WVE-007, which has sparked intense debate over its long-term potential compared to GLP-1 incumbents. While some investors are bullish on the company's RNA-based platform and its unique ability to reduce visceral fat while preserving muscle mass, others remain skeptical about the trial design and are wary of potential further downside as analysts balance ambitious price targets against the challenges of a crowded obesity pipeline.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV investors are reacting negatively to a recent reverse stock split, with many in the community expressing extreme frustration over a lack of communication from management and a sharp decline in share price. Discussion is dominated by concerns over the company's long-term viability, allegations of market manipulation, and intense debate regarding whether the stock is an oversold buying opportunity or a value trap heading toward bankruptcy.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors grapple with concerns over high AI capital expenditures and a potential slowdown in software revenue growth, leading to a persistent decline in share price. The community is deeply divided between those viewing the current drop as an oversold, generational buying opportunity and those fearing a deeper structural breakdown in the stock's long-term momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quaker Chemical (KWR) Down 23.3% Since Last Earnings Report: Can It Rebound?

Quaker Chemical (KWR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

KOP's Multi-Year Tailwind: Grid Buildout & Rail Spend in Focus

Koppers rides multi-year grid and rail spend, leaning on mix shift, share gains and cost cuts to steady earnings despite uneven markets.

KOP Stock: Can Utility Strength & PC Gains Offset Cost Pressures?

Koppers leans on utility demand and PC share gains for 2026, but commodity costs, tariffs and CMC turmoil keep execution and margins in focus.

JPMorgan Chase & Co. Reduces Position in Quaker Houghton $KWR

JPMorgan Chase & Co. lessened its holdings in shares of Quaker Houghton (NYSE:KWR - Free Report) by 11.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 654,245 shares of the specialty chemicals company's stock after selli...

Penn Capital Management Company LLC Sells 12,903 Shares of Quaker Houghton $KWR

Penn Capital Management Company LLC reduced its stake in shares of Quaker Houghton (NYSE:KWR - Free Report) by 65.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,859 shares of the specialty chemicals company's stock...

Quaker Chemical and EV Fluids: Why APAC Wins Matter in 2026

KWR leans on APAC growth and EV wins to fuel 2026 outgrowth, with China expansion, Dipsol synergies and share gains offsetting soft markets.

KWR Stock: Undervalued Play or Execution Risk Waiting to Unfold?

KWR trades at a discount after sharp declines, as investors weigh margin targets and share gains against tariffs, flat demand and rising costs.

Can Execution Power Quaker Chemical's Growth in a Soft Market?

KWR eyes 2026 share gains and margin lift despite soft demand, leaning on APAC momentum, China capacity and cost savings to drive steady growth.

Quaker Houghton $KWR Stock Position Increased by Dean Capital Management

Dean Capital Management lifted its stake in Quaker Houghton (NYSE:KWR - Free Report) by 163.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange...

Kennedy Capital Management LLC Trims Holdings in Quaker Houghton $KWR

Kennedy Capital Management LLC lowered its holdings in shares of Quaker Houghton (NYSE:KWR - Free Report) by 8.6% in the third quarter, according to the company in its most recent filing with the...

Quaker Houghton engages in the development and production of formulated specialty chemical products and offers chemical management services for various heavy industrial and manufacturing applications. The firm operates through the following geographical segments: Americas, Europe, Middle East and Africa, and Asia Pacific. Its products include can making lubricants, cleaners, coatings, cold rolling oils, corrosion preventives, die casting lubricants, dust suppressants, greases, ground control agents, hot rolling oils, hydraulic fluids, industrial lubricants, longwall fluids, metal forming fluids, metal removal fluids, pickle oils, surface treatments, temper fluids, and tin plating. The company was founded in 1918 and is headquartered in Conshohocken, PA.

Quaker Houghton

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

KWR
Quaker Houghton

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KWR News

KWRQuaker Houghton